Clinical TrialID 8180

Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment Response

NCT05692843

Atopic Dermatitis

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
8180
Evidence Id
8180
Core Evidence Id
8180
Source Clinical Trial Id
8178
Herb2 Clinical Trial Id
HBCT008178
Nct Id
NCT05692843
Title
Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment Response
Status
Recruiting
Phase
Phase 4
Study Result
No
Study Condition
Atopic Dermatitis
Study Type
Interventional
Study Design
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Intervention
DRUG: Cyclosporin A|OTHER: Follow-up of Cyclospoin treatment already started
Intervention Allocation
Non_Randomized
Intervention Model
Single_Group
Intervention Mask
Intervention Purpose
Treatment
Gender
All
Age
Child, Adult, Older_Adult
Enrollment
100
Outcome Measure
Percentage of patients with primary non-response to treatment with cyclosporine., Fail to achieve EASI-75 (a 75% improvement in EASI score), Week 16
Sponsor Collaborator
Instituto de Investigación Hospital Universitario La Paz
Funded By
OTHER
Location
Hospital La Paz, Madrid, 28046, Spain
Other Id
2022-500677-14-00
Start Date
2022-10-10
Primary Completion Date
2023-11
Completion Date
2024-07
First Posted
2023-01-20
Results First Posted
Last Update Posted
2023-04-28
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05692843
Title Cn
Title En
Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment Response
Bilingual Status
semi_complete